Origins of Alzheiemr’s disease: reconciling cerebrospinal fluid biomarker and neuropathology data regarding the temporal sequence of amyloid beta and tau involvement

December 1, 2012

David Holtzman

Diagnosis of Alzheimer’s disease using laser-induced breakdown spectroscopy and machine learning

January 30, 2024

Weiming Xia

Major Differences between the Self-Assembly and Seeding Behavior of Heparin-Induced and in vitro Phosphorylated Tau and their Modulation by Potential Inhibitors

January 30, 2024

Gal Bitan

Soluble SORLA enhances neurite outgrowth and regeneration through activation of the EGF Receptor/ERK signaling axis

January 30, 2024

Huaxi Xu, Timothy Huang, William C. Mobley

Valerija Dobricic

Dr. Dobricic received her Bachelor’s degree in Molecular Biology and Physiology in 2003 and her Master’s degree in Molecular Biology and Biochemistry in 2005, both from the Faculty of Biology, University of Belgrade, Serbia. In 2013, she completed her Ph.D. at the Faculty of Medicine, University of Belgrade. From 2008 ...

February 6, 2024

Valerija Dobricic

Impact of APOE on amyloid and tau accumulation in argyrophilic grain disease and Alzheimer’s disease

February 9, 2024

Guojun Bu, Ronald C. Petersen, Takahisa Kanekiyo

Nonlinear Relation between Body Mass Index and Long-Term Poststroke Functional Outcome-The Importance of Insulin Resistance, Inflammation, and Insulin-like Growth Factor-Binding Protein-1

April 30, 2024

Henrik Zetterberg

Modulating Self-Assembly of Amyloidogenic Proteins as a Therapeutic Approach for Neurodegenerative Diseases: strategies and mechanisms

January 30, 2024

Gal Bitan

Safety and pharmacological characterization of the molecular tweezer CLR01- a broad spectrum inhibitor of amyloid protein’s toxicity

January 30, 2024

Gal Bitan

Modulation of amyloid beta-protein (A beta) assembly by homologous C-terminal fragments strategy for inhibiting Amyloid beta toxicity

January 30, 2024

Gal Bitan